ABSTRACT The potential benefits of a high fruit and vegetable intake on the antioxidant status and on relevant biomarkers of oxidative damage to lipids, proteins and DNA and on (functional) markers of oxidative stress were evaluated. A randomized, free living, open placebo-controlled cross-over trial of 3 wk, with a 2-wk washout period between treatments, was performed in a group of 22 male smokers with a relatively low vegetable and fruit intake using a vegetable burger and fruit drink. The vegetable burger and fruit drink increased serum levels of vitamin C, ␣-carotene, ␤-carotene, ␤-cryptoxanthin and zeaxanthin and plasma total antioxidant capacity. However, no effects were demonstrated on any marker of oxidative damage to lipids (malondialdehyde F 2 -isoprostane) proteins (carbonyls) and DNA (Comet assay) and (functional) markers of oxidative stress (reduced/oxidized glutathione ratio, glutathione-S-transferase ␣, glutathione-S-transferase and nuclear transcription factor-B). Apparently, these increased levels of antioxidants in serum were not sufficiently high to show beneficial changes with the selected biomarkers. Alternatively, oxidative stress in male smokers with a relatively low fruit and vegetable intake might have been still too low to demonstrate a beneficial effect of antioxidants.
A high consumption of fruit and vegetables has been associated with lower incidence and mortality rates of cancer, as found in several human cohort and case-control studies and for a number of common cancer sites (1) . This is in line with many animal experiments showing that vegetables that are common in human diets have antitumorigenic effects (2) (3) (4) .
Protection against cardiovascular disease by a high consumption of fruits and vegetables has also been suggested (5, 6) . Additional evidence comes from preclinical studies, such as in vitro or animal studies (7) . However, such data are of limited value because of difficulties in extrapolating to the human situation, e.g., due to uncertainties with respect to bioavailability and tissue distribution or, as in animal models, differences in metabolism and metabolic rate (8) .
The potential health benefits of fruits and vegetables have been attributed to the effects of specific ingredients in fruits and vegetables, such as vitamins, dietary fiber and a wide range of bioactive compounds, such as flavonoids. Antioxidant activity is considered to play an important role in the protective effects of fruits and vegetables (9 -13) . This is in part based on the increasing evidence that oxidative damage is involved in the pathogenesis of atherosclerosis and in carcinogenesis (14, 15) .
The aim of the present study was to evaluate the sensitivity of biomarkers of oxidative damage and (functional) biomarkers of oxidative stress and the potential to demonstrate beneficial effects with these biomarkers in a potential risk group with a relatively low "habitual" vegetable and fruit consumption using "natural" products. In this report, we describe the results of a cross-over intervention study with antioxidants in a "natural" matrix and other bioactive compounds from fruit and vegetables in a group of male smokers with a relatively low habitual fruit and vegetable intake. We used a vegetable burger (VB) 2 with commercially available lyophilized vegetables, containing the equivalent of ϳ500 g mixed "fresh" vegetables (tomatoes, carrots, onions, broccoli and red sweet pepper) per daily portion and a fruit drink (FD) prepared from fruit (orange, blueberry, apple, lemon and lime) concentrate. The vegetables and fruits selected for preparation of the test products were considered to be significant sources of antioxidants associated with the beneficial health effects, as suggested in observational epidemiological and experimental studies (12,16 -18) .
The effects of the VB/FD on the antioxidant status (vitamins C and E, retinol, carotenoids), plasma trolox equivalent antioxidant capacity (TEAC) and selected biomarkers of ox-idative damage [malondialdehyde (MDA), F 2 -isoprostane, protein carbonyls, DNA damage (Comet assay)] and oxidative stress [reduced/oxidized glutathione ratio (GSH/GSSG ratio), glutathione-S-transferases (GST␣, GST)] were assessed. Activity of the nuclear transcription factor-B (NF-B) was determined in peripheral blood mononuclear cells (PBMC). This factor is involved in carcinogenic and inflammatory processes and is under redox control, i.e., activated under conditions of increased cellular oxidative stress (19) , and therefore is considered as an early functional marker of oxidative stress.
SUBJECTS AND METHODS

Subjects
The study was performed according to the guidelines for Good Clinical Practice of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use at the Department of Nutritional Physiology of TNO Nutrition and Food Research, Zeist, the Netherlands. The protocol was approved by the local medical ethics committee.
Smoking, male (aged 18 -50 y) subjects were recruited from the pool of volunteers of the institute. The protocol was carefully explained to the volunteers, and their written informed consent was obtained. Subjects were eligible if they fulfilled the following inclusion criteria: i) apparently healthy as indicated by a general medical questionnaire, physical examination and a "normal" clinical chemical blood profile, ii) currently smoking Ն10 cigarettes/d for Ն1 y and no intention to stop during the study period, iii) a body mass index [BMI; body weight (kg)/height (m 2 )] Յ 30, iv) low use of vegetables, fruits and fruit drinks as assessed by a food frequency questionnaire (subjects with the lowest quantified vegetable/fruit intake were selected), v) moderate alcohol consumption of Յ28 U/wk (1 U ϭ 10 g alcohol), vi) regular (Dutch) food pattern and vii) no use of vitamin and/or food supplements.
Twenty-four men entered the study. Two subjects withdrew during the first treatment period of the study due to dislike of the test products. One subject withdrew on d 1 and was replaced. Therefore, data for 21 subjects were available on d 1 and data for 22 subjects were available on d 22 and 57.
Study design
The study was designed as a randomized, free living, open placebocontrolled cross-over trial. The study consisted of two treatment periods of 3 wk with a 2-wk washout period between periods. Each subject received test products (VB/FD) and the respective control products [control burgers and control drinks (CB/CD)] in a randomized order. Subjects were instructed to maintain their usual diet and to use one portion of either test products or control products per day during 3 wk at a self-selected moment but not replacing a meal. Half of the subjects started with the test products for 3 wk and changed over after 2 wk washout to the control products; the other half of the subjects did the opposite. Each week, volunteers were supplied with fresh products and instructed to store the products in a refrigerator.
At d 1, 22 and 57, body weight was assessed with the subject wearing indoor clothing, without shoes, wallet and keys. Systolic and diastolic blood pressure and heart rate were measured oscillometrically in a sitting position and in the right arm after a Ն5-min rest. Blood samples were collected for analysis of various status, damage and stress variables as described later.
Test products
A VB was prepared using commercially available lyophilized vegetables, provided by Keizer Waalwijk BV, the Netherlands (lyophilized by Kerry Ingredients BV, the Netherlands) and an FD prepared from fruit juice concentrates (SVZ International, Etten-Leur, the Netherlands).
The VB, of ϳ100 g, contained the equivalent of ϳ500 g mixed "fresh" vegetables, consisted of 40 g mixed freeze-dried vegetables (equivalent to ϳ85 g broccoli, 47 g tomato, 84 g carrot, 99 g red sweet pepper and 156 g onion), mixed with 39.5 g chicken meat, 5 g of palm oil carotenoids (in corn oil; Quest International, Maarssen, the Netherlands) and a mix of spices ( Table 1) . The FD, of ϳ330 mL, consisted of a mixture of tap water-diluted juice concentrates of orange (30%), blueberry (30%), apple (30%), lemon (5%) and lime (5%).
The control product was a CB, of ϳ100 g, that consisted of 70.5 g chicken meat, 11 g of corn oil and a mix of spices (similar as in test product; Table 1 ). The CB had a similar energy content, macronutrient composition and texture as the VB. The CD was a drink of ϳ330 mL water and fructose (0.2 g/L). The CD had a similar energy content as the FD. The ingredients of the VB and FD were selected for their high antioxidant contents and mixed in a ratio to achieve tasteful products.
Blood samples
On d 1, 22 and 57, blood samples were collected from fasting subjects, between 0800 and 0930 h. For analysis of vitamins A and E, carotenoid profile, triglycerides, total cholesterol and HDL cholesterol, blood was collected in tubes containing clot activator (Vacutainer systems; Becton Dickinson, Leiden, the Netherlands) and further prepared on ice under subdued light. Within 30 min, the tubes were centrifuged (10 min at 2000 ϫ g at 4°C). Serum samples for analysis of vitamins A and E and carotenoid concentrations were stored at ϽϪ70°C until analysis. Samples for analysis of triglycerides and total and HDL cholesterol were stored at ϽϪ18°C and , and subsequently PBMC were collected, washed twice and divided over the aliquots needed. Cell concentrations were determined, and samples were directly used for analysis of GST-and for isolation of nuclear proteins (NF-B) or stored at ϽϪ70°C for analysis of DNA breakage. For analysis of GSH/GSSG ratio, blood was placed on ice, centrifuged (5 min at 5000 ϫ g) and immediately used for determination of GSH/GSSG in erythrocytes. The resulting erythrocytes were washed, and 1 mL of 10 mmol HCl/L plus 6.5% 5-sulfosalicyl acid was added to 450 L erythrocytes, mixed and put on ice for 10 min. Samples were centrifuged (15 min at 2000 ϫ g at 4°C), and the supernatant was rapidly frozen on dry ice and stored at ϽϪ70°C.
Biochemical and chemical analyses
Characterization of products. All study products (VB/FD and CB/CD) were characterized by chemical analysis of macronutrient composition and antioxidant contents. Protein, carbohydrate and total fat concentrations were analyzed using standard methodology, and energy values were calculated based on the results of macronutrient composition.
The antioxidant content was established by analyses of vitamin C, total vitamin E (only burgers) and carotenoid profile. For vitamin C analyses, VB and CB were first extracted with trichloroacetic acid and FD and CD were deproteinated with metaphosphoric acid, followed by filtration, oxidation to dehydro-L-ascorbic acid and condensation according to a method reported by Speek et al. (20) .
Total vitamin E and carotenoid concentrations were analyzed after saponification with KOH followed by extraction with diisopropylether and HPLC with fluorometric detection for vitamin E (21) and spectrophotometric detection for carotenoids (22) . The results of the macronutrient composition (protein, carbohydrate and fat), carotenoid profile (lutein, zeaxanthin, ␤-cryptoxanthin, lycopene, ␣-carotene and ␤-carotene), vitamin E and vitamin C concentrations of the burgers and drinks (except for vitamin E) are summarized in Table 2 .
In addition, flavonoid analysis was performed using HPLC equipped with photodiode array detection according to a method described by Hertog et al. (23). Briefly, before extraction, VB and CD were ground under nitrogen followed by lyophilization. Subsequently, the flavonoids were extracted, and the extract was filtered. The filtrate was transferred onto a preconditioned SPE C18 cartridge and quantitatively eluted from the column. The eluate, containing the glycosylated flavonoids, and the drinks (FD, CD) was acidified with concentrated HCl and hydrolyzed for 2 h at an elevated temperature. Deglycosylated flavonoids were analyzed using an Alliance 2690 HPLC system, equipped with a Hypersil BDS column (4.6 ϫ 250 mm) and photodiode array detection. Compounds were quantified at compound-specific absorption maxima.
The in vitro antioxidant capacity was measured as the Trolox equivalent antioxidant capacity (TEAC) as described by van den Berg et al. (24). Briefly, VB and CB were extracted with 70% methanol. Samples of VB/CB or FD/CD were added to an 2,2Ј-azinobis-(3-ethylbenzthiazoline-6-sulfonate) radical solution, and the decrease in radical concentration was monitored spectrophotometrically.
Blood lipid and antioxidant measurements. Serum lipids and serum triglycerides were analyzed by enzymatic hydrolysis with subsequent enzymatic determination of the liberated glycerol by colorimetry (Boehringer, Mannheim, Germany). Total cholesterol was analyzed by enzymatic conversion to a stable chromogen, which can easily be detected with colorimetry (Boehringer). HDL cholesterol was analyzed by precipitation with polyethylene glycol, centrifugation and enzymatic detection by colorimetry (Boehringer), and LDL cholesterol was calculated using the Friedewald formula (25) .
Total antioxidant capacity as measured by the TEAC was determined according to the method described (24). Briefly, plasma samples were deproteinized by adding an equal volume of 10% trichloroacetic acid. After centrifugation, the supernatant was added to an 2,2Ј-azinobis-(3-ethylbenzthiazoline-6-sulfonate) radical solution. The decrease in radical concentration was monitored spectrophotometrically and related to the decrease obtained with Trolox.
Serum vitamin A and E and carotenoid concentrations were quantified by reversed phase HPLC using a modified version of a method described previously (22) . Tocopherols were quantified by fluorometric detection, and vitamin A and carotenoid profiles were quantified with diode array detection.
Vitamin C in deproteinized blood was analyzed by an HPLC method with fluorometric detection (20) . Vitamin C was oxidized to dehydroascorbic acid and subsequently condensed with 1,2-diaminobenzene to quinoxaline, which was detected.
Lipid, protein and DNA oxidative damage. MDA was determined in plasma by derivatization of MDA with thiobarbituric acid and quantified by HPLC separation with a fluorometric detector according to a method described by Fukunaga et al. (26) . Plasma 8-epi-prostaglandin F 2␣ was measured according to a method described by Nourooz-Zadeh et al. (27) with some modifications. This method involves solid-phase extraction and conversion to pentafluorobenzyl ester and trimethylsilyl ether derivatives. 8-Epi-prostaglandin F 2␣ was quantified using negative-ion chemical ionization high resolution mass spectrometry. Plasma protein carbonyl content was quantified by the reaction with 2,4-dinitrophenylhydrazine, as previously described by Buss et al. (28) , using an enzyme-linked immunosorbent assay. DNA oxidative damage, measured as the Comet assay, was conducted as described by Collins et al. (29) . The DNA strand breaks were analyzed in untreated, H 2 O 2 -treated (to monitor resistance of the cells to oxidative stress) and endonuclease III-treated (to detect levels of oxidized pyrimidine bases) isolated human PBMC. Comets were analyzed quantitatively (100 cells per samples) using image analysis software (Comet Assay II; Perceptive Instruments, Suffolk, U.K.). The tail moments were converted to visual scoring system (Collins score) from class 0 (no damage) to class 4 (almost all DNA in tail).
Markers of oxidative stress. The GSH/GSSG ratio was determined in erythrocytes according to the method described by Baker et al. (30) using the enzymatic DTNB-reductase recycling method. Reduced glutathione (GSH) is oxidized by DTNB leading to the formation of oxidized glutathione (GSSG) and TNB (5-thio-2-nitrobenzoic acid). The formation of TNB was measured at 405 nm. GSSG was determined after derivatization of GSH with 2-vinylpyridine.
GST-␣ enzyme activity in plasma was analyzed using the Biotrin HEPKIT-Alpha kit (Biotrin International, Dublin, Ireland) for quantitative determination of GST-␣, and GST-in PBMC was analyzed using the Biotrin HEPKIT-Pi kit (Biotrin International) for quantitative determination of GST-.
NF-B activity in PBMC was analyzed according to method described by van den Berg et al. (31) as a "functional" marker of oxidative stress. The electromobility shift assay (EMSA) with phosphor imaging was used to detect NF-B. For the quantification of NF-B activity, a commercially obtained HeLa nuclear (protein) extract (Promega Benelux, Leiden, The Netherlands) was used as a standard on each gel. NF-B activity was expressed as HeLa equivalents/10 g protein.
Statistical analysis
Data were analyzed using the SAS statistical software package (SAS/STAT Version 6; SAS Institute, Cary, NC). All data are expressed as means Ϯ SD. Effects of consumption of the vegetable and fruit concentrates on variables measured were tested by analysis of variance using the General Linear Model procedure. Only the 22 subjects with results for both treatments were included in the analysis. Results are based on those 22, unless indicted otherwise in the tables. Differences were considered significant at 0.05.
RESULTS
Volunteers
The 22 men which entered the study were 33 Ϯ 11 y old (range, 19 -49 y), had a BMI of 23.6 Ϯ 3.0 kg/m 2 (range, 19.1-28.5 kg/m 2 ) and smoked 18 Ϯ 7 cigarettes/d (range, 10 -40 cigarettes/d). The vegetable and fruit intake of the men, as assessed by a food frequency questionnaire, was estimated to be 167 g/d, which is around the 50th percentile of the Dutch male population (174 g/d) (32) . The test products were well tolerated by the subjects, and compliance to the study protocol was good (Ͼ98% of all study products were used), as judged from the reported product consumption and the return of the remaining products. Subjects' smoking habits were the same for both treatment periods, as judged by the returned question forms. None of the subjects had to be excluded due to illness.
Body weight, blood pressure, heart rate and serum lipid concentrations were not affected by the treatments ( Table 3) .
Study parameters
Antioxidant status. Serum vitamin C level was significantly increased (P Ͻ 0.0001) after the VB/FD treatment compared with the CB/CD treatment ( Table 4) . Serum levels of ␣-carotene, ␤-carotene, ␤-cryptoxanthin and zeaxanthin were also significantly higher (P Ͻ 0.0001) after the VB/FD treatment, whereas serum lycopene and lutein levels did not differ between treatment periods (Table 4) . Plasma TEAC was significantly increased after consumption of the VB and FD compared with the control products (Table 4) . Serum retinol and tocopherol concentrations were not affected by the VB/FD treatment (Table 4) .
Lipid, protein and DNA oxidative damage. Plasma MDA, protein carbonyls and 8-epi-PGF 2 levels were not affected by the type of treatment ( Table 5) . DNA breakage (in PBMC), expressed as Collins scores (blank and, respectively H 2 O 2 and endonuclease-III treated) also did not differ due to the treatments (Table 5) .
Markers of oxidative stress. Baseline levels and the effect of treatment on GST-␣ and GST-, GSH, GSSG, the GSH/ GSSG ratio and NF-B activity (in PBMC) are summarized in Table 6 . GST-␣ activity did not differ between treatments, but GST-activity was slightly, but significantly, lower at the end of the vegetable treatment period compared with the end of the control treatment (P ϭ 0.048). Erythrocyte levels of GSH and oxidized GSSG, respectively, the GSH/GSSG ratio, were not affected by the type of treatment. The NF-B activ- ity, expressed as HeLa equivalents/10 g protein also was not affected by the type of treatment.
DISCUSSION
Observational epidemiological studies have consistently shown that a diet rich in fruit and vegetables is associated with a lower risk of specific cancers and of cardiovascular disease (1, 5) . Oxidative stress and oxidative damage are considered to play a role in the early stages of the pathophysiological processes of both diseases. Many studies have already explored the potential of selected nutrients and bioactive compounds, present in fruit and vegetables, on a range of biomarkers of (in vitro) oxidative stress and/or oxidative damage. Significant and possibly relevant effects have been reported, especially for the antioxidant vitamins C (33) and E (34) and ␤-carotene (35). However, there is a discrepancy between the outcome of the observational and experimental studies and the few controlled intervention studies investigating the effect of high dose supplementation on cancer or cardiovascular disease mortality and morbidity reported so far. This discrepancy may partly be explained by the fact that in the intervention studies, synthetic (pure) compounds were given in relatively high dosages compared with the level present in natural food. Moreover, other compounds in the food matrix may have a health beneficial effect, not necessarily associated with an antioxidant action. One complicating factor in interpretation of the (experimental) studies is our lack of knowledge with respect to the critical pathophysiological processes and the consequent questions with respect to validity and relevance of the various biomarkers used.
The aim of this study was to evaluate the sensitivity of a number of biomarkers of oxidative damage and (functional) biomarkers of oxidative stress and to demonstrate beneficial effects with these biomarkers, in a potential risk group of smoking males with a relatively low habitual fruit and vegetable consumption, by increasing their intake of natural antioxidants and of other bioactive compounds from fruit and vegetables.
From the results as summarized in Tables 5 and 6 , it is, however, clear that no effect on markers of oxidative lipid, protein, DNA damage and functional markers of oxidative stress could be demonstrated after a treatment period of 3 wk with these test products.
To account for these findings and apparent discrepancies with reported studies, the following items are discussed: i) the additional antioxidant dose achieved by the test products in relation to the anticipated response and ii) the study design, i.e., "suitability" of the study population and "power" of the study. Antioxidant dose achieved by the test products in relation to the anticipated response (antioxidant status). Analysis of the VB/FD, summarized in Table 2 , showed that these products indeed contained substantial amounts of antioxidants and had a high potential (TEAC). The high TEAC of the VB and the FD is largely explained by the high vitamin C content (118 mg in the VB and 53 mg in the FD) and the contribution from other natural antioxidants, such as flavonoids. Consumption of these products did indeed result in an increase in the serum levels of vitamin C, ␣-carotene, ␤-carotene, ␤-cryptoxanthin and zeaxanthin, respectively, as well as in an increased total plasma antioxidant capacity, measured as the TEAC (Table 4 ). The main contribution to the product TEAC comes from vitamin C and the flavonoids, whereas carotenoids do not, or only minimally, contribute (24). The total flavonoid content measured in the product was ϳ28 mg for the VB and ϳ57 mg in the FD, and ϳ20 -30% of the TEAC might be explained by the flavonoids and other bioactive compounds with antioxidant capacity present. An uncertain factor is the bioavailability and postprandial metabolism of flavonoids contained in the products. As far as data are available, it seems that bioavailability of flavonoids is generally low (36) . Plasma flavonoid levels were not determined, but the increase in plasma TEAC might be in part explained by these compounds (or metabolites).
The additional amount of vitamin E provided by the VB was ϳ8.2 mg ␣-tocopherol equivalents (␣-TE) and ϳ3.0 mg ␣-TE for the CB. According to Traber and Sies (37), a daily dietary intake of ϳ15-30 mg ␣-tocopherol would be needed to reach an "optimal" plasma ␣-tocopherol level above 30 mol/L, associated with lower cardiovascular and cancer risk. We have no data on the actual total dietary vitamin E intake in our subjects, but serum ␣-tocopherol levels were slightly below 30 mol/L. Observational epidemiological and intervention studies indicate that the major effect (if any) of vitamin E supply are found only with a daily intake higher than 74 mg ␣-TE (34). Therefore, the amount used in the present study apparently was not sufficient to increase the serum tocopherol level and/or to affect parameters of oxidative damage and stress.
The carotenoid content of the VB was at least 50 -70% lower as expected from the contents in the equivalent "fresh" vegetables. Lycopene content was 1.3 mg, whereas ϳ3 mg was expected on the basis of ϳ47 g "fresh" tomatoes. For lutein, the expected content was ϳ3 mg, but only 0.85 mg was detected. Apparently, losses have occurred in production of the VB, which included blanching and freeze-drying (35).
The lowest lycopene intake reported to increase plasma lycopene levels is 3.3 mg in heat processed vegetable juice given for 15 d (38) . In other studies, using tomato products, higher amounts were achieved, such as 40 mg/d (39), 16.5 mg/d (40) or 10 mg/d (41) to increase plasma lycopene levels. The bioavailability of lycopene, which depends on the matrix, is also an important factor. Bohm and Bitsch (42) reported that lycopene from capsules and tomato juice (processed tomatoes) was better absorbed from the intestine than lycopene from raw tomatoes. They also showed that administration of 5 mg lycopene/d did not affect plasma antioxidant capacity. If the protective effect of tomatoes on prostate cancer risk is indeed due to lycopene then the protective lycopene intake should be Ն6.5 mg/d (17). In the present study, the additional intake of lutein and lycopene from the burger was apparently too low to achieve an increase of serum levels. The VB/FD provided per day an additional 4.0 mg ␣-carotene and 9.0 mg ␤-carotene. This resulted in an increase in plasma ␣-and ␤-carotene. ␤-Cryptoxanthin and zeaxanthin levels were also increased, but the obtained higher levels were not associated with changes in oxidative stress and damagerelated markers. Using data reported in the various epidemiological trials on cardiovascular risk and mainly observational studies, a threshold level for serum ␤-carotene of 0.4 mol/L has been derived (43) . This level is reached at an intake of Ն1.5-2 mg ␤-carotene/d. We have no data on the actual total ␤-carotene dietary intake in our subjects, but ␤-carotene levels were ϳ0.3 mol/L after CB/CD and 0.67 mol/L after VB/FD treatment. "High dose" supplementation with synthetic ␤-carotene in smokers has been associated with an increased risk for lung cancer (44,45).
Previously, reduced genetic damage by natural products has been reported in humans, using the Comet assay (39). After a 2-wk carotenoid depletion period, followed by a daily intake for 2 wk of 330 mL tomato juice (containing 40 mg lycopene) or 330 mL carrot juice (containing 22.3 mg ␣-carotene and 15.7 mg ␤-carotene) or 10 g dried spinach powder (containing 11.3 mg lutein), a significant decrease in endogenous levels of strand breaks in lymphocyte DNA has been found.
Vitamin C is an important contributor to the oxidant defense system and has been shown to protect against in vivo oxidation of lipids and DNA in humans, particularly in persons exposed to enhanced oxidative stress, such as smokers (33, 46) . Numerous epidemiological studies strongly suggest that 90 -100 mg vitamin C/d (33), and plasma concentrations of Ͼ50 mol/L (47) have been associated with a lower incidence and mortality from cardiovascular disease and cancer.
The VB/FD provided an additional vitamin C intake of 170.5 mg/d. This resulted in an increase in plasma vitamin C level of ϳ20 mol/L. This increase likely explains the increase in plasma TEAC (ϩ38 mol/L). Calculated using the TEAC of 1 for vitamin C (24), the contribution of vitamin C to the increase in TEAC is ϳ83%. However, for analysis of plasma TEAC, no precautions could be taken to prevent loss of vitamin C, as done for analysis of vitamin C, and therefore the contribution of vitamin C to the increase in TEAC might be overestimated.
In our subjects, vitamin C levels were ϳ40 mol/L before and 58 mol/L after VB/FD treatment. This is in line with kinetic data showing an increase in fasting plasma levels of vitamin C to ϳ60 mol/L, after a 200-mg dose (48) .
High dose supplementation with vitamin C (500 mg/d) has been shown to elevate red blood cell glutathione in healthy adults (49) . Erythrocyte glutathione oxidation is considered to be a consistent marker of oxidative stress (50) .
In our study, the GSH/GSSG ratio was not altered, but GSH levels appeared to be lower than baseline after both treatments. Hininger et al. (41) reported increased GSH levels in smokers, which also decreased to the "normal" nonsmoking levels after a fruit and vegetable-rich diet. This increase was unrelated to an increase in GSSG. The observed higher GSH in erythrocytes of smokers might reflect an adaptation to enhanced production of reactive oxygen species from cigarettes.
Duthie et al. (51) reported that supplementation of the diet for 20 wk with vitamin C (100 mg/d), in combination with vitamin E (280 mg/d) and ␤-carotene (25 mg/d), resulted in a highly significant decrease in endogenous oxidative base damage in lymphocyte DNA of both smokers and nonsmokers. In addition, lymphocytes of antioxidant supplemented subjects showed an increased resistance to oxidative damage when challenged in vitro with H 2 O 2 .
Effect on (functional) markers of oxidative stress. Antioxidant status and markers of oxidative damage (DNA adducts, lipid and protein oxidation products) are frequently used to assess antioxidant and pro-oxidant effects. However, gene expression, being an important modulator of cell functions, has been shown, in some cases, to be under redox control. Changes in gene expression can provide a sensitive marker of oxidative stress (or changes in oxidative status). A well-defined transcription factor, NF-B, has been identified to be regulated by the intracellular redox state. Activation of the transcription factor NF-B was measured in this study to assess the potential of these markers as a 'functional' marker of oxidative stress. This redox-controlled mechanism is quite distinct from the response to antioxidant that involves upregulation of certain specific genes (e.g., glutathione-S-transferase) as a consequence, for example, of the antioxidant responsive element present in the promotor. Such genes respond to a diverse selection of antioxidants and might reflect changes in oxidative status. Induction of both glutathione-Stransferases (GST-␣ and GST-), a family of phase II enzymes, was measured in this study to assess the potential of these markers as markers of oxidative stress.
Induction of phase II enzymes has been postulated as a key mechanism for the anticarcinogenic effects of fruits, vegetables and antioxidants (52) (53) (54) . GST are able to conjugate electrophiles with glutathione or by a glutathione-dependent peroxidase activity. They may also participate in the repair of cellular macromolecules damaged by oxidative stress. In addition, GST-can react directly with reactive oxygen species via a sensitive SH-group or be inactivated by disulfide formation that can be reversed by glutathione. Therefore, it has a specific response to oxidative stress (55) . Several genetic elements in the promoter regions of the genes encoding phase II enzymes have been identified. GST-is regulated by the redox status of the cell (55) . In the regulatory element of the GSTgene, an antioxidant responsive element, as well as a NF-Bbinding site, has been identified.
In our study, GST-was lower after treatment with the VB/FD compared with the CB/CD. This is in contrast with a previous study with nonsmokers, where an induction of GST-was observed in 6 of the 23 subjects after treatment with tomato and carrot juices (39). Smokers may have higher levels of GST-compared with nonsmokers to protect them against oxidative stress caused by smoking. A higher intake of antioxidants prevents formation of reactive oxygen species, and therefore GST-is down-regulated.
NF-B is activated by oxidative stress, and this enhanced activity can be modulated by antioxidants (56) . To assess in vivo NF-B activity, the activation was measured in freshly isolated PBMC. In a previous study, we found a higher NF-B activity in male "heavy" smokers compared with nonsmokers (57). Because of the high TEAC of the VB/FD, the relatively high concentrations of vitamin C and quercetin, a decrease in NF-B activation was anticipated. In vitro reduction of NF-B activation by antioxidants has been reported, such as by vitamin C, vitamin E and resveratrol (19, 58) . However, we did not find a counteraction in the present study.
Study design: "suitability" of the study population and test products, "power" of the study. The study was designed as a randomized, free living, open, placebo-controlled, cross-over study to simulate the normal home situation and intervention with processed vegetables, rather than with food supplements. Compliance was checked and considered adequate. Subjects supplemented the product to their usual diet. However, no further data on the actual fruit and vegetable intake during the study were collected. Replacement of other food products and changes in dietary pattern as a result of the intervention per se therefore cannot be excluded but, if any, should be balanced by the cross-over design with isoenergetic placebo products. Also, the selection of male smokers with a relatively low fruit and vegetable intake on the basis of food questionnaires might have been insufficiently discriminative to select subjects with increased oxidative stress. In some studies, e.g., Bub et al. (59) , a depletion stage was included in which subjects are fed a "low carotenoid diet" before the actual intervention, which might increase the sensitivity and power of the design to demonstrate effects.
Smokers are considered to be exposed to an increased oxidative stress, because of their apparent lower antioxidant intake (60) in combination with a relatively high free radical exposure. Several studies have been reported showing lower antioxidant vitamin and/or carotenoid plasma levels in smokers (41, 61, 62) . This also is true with respect to markers of oxidative damage, such as increased plasma conjugated dienes (63) , increased oxidative DNA damage (51) or increased plasma levels of F 2 -isoprostanes (64) .
We recently reported that (baseline) NF-B activity is higher in male smokers compared with nonsmokers (57). However, we did not compare the present baseline data with those for a comparable group of nonsmokers. Comparison with values reported by other groups is complicated because of methodological differences and, for some markers, relatively large interassay variabilities.
Test products. To maximize the intake of natural antioxidants, we used a VB and an FD, prepared from commer-cially obtained ingredients (freeze-dried vegetables and fruit extracts), selected because of their potential antioxidant contents and reported health effects. These VB/FD had indeed relatively "high" TEAC, but for some compounds, such as the carotenoids, the actual additional intake achieved was lower than anticipated, most probably because of losses during processing of the extracts/lyophilized products. As discussed above, carotenoid and vitamin E levels were apparently too low to achieve an effect, if any, on the markers evaluated in this study.
Power of the study. The relatively low antioxidant content of the test products and/or the low level of oxidative stress in the study population may explain the lack of effects of fruits and vegetables supplementation on the selected biomarkers in our study. To assess the sensitivity of these markers, we used our data set to calculate the number of subjects needed to demonstrate a 10% difference between treatments (␣ ϭ 0.05, two-sided and a power of 80%). Based on the observed withinsubject variability during treatment with the control products, we calculated that for some of the biomarkers, the number of subjects was indeed insufficient. Table 7 shows that in our study, using 22 subjects, only an effect (10% difference) on protein carbonyls and plasma TEAC could have been demonstrated.
Whether an effect of 10% is also functionally relevant is another issue, which remains unanswered. Answering this question requires a better understanding of the underlying pathophysiology, and further standardization and validation of biomarkers, by relating responses in biomarkers to hard end points of the disease. This will require further (intervention) studies, using subjects with an established oxidative stress, or in patients with a disease associated with increased oxidative stress such as in diabetes or with inflammatory diseases. This seems an ambitious but essential task to make further progress. 
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